Ceapro Inc
XTSX:CZO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.9
12.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Ceapro Inc
Ceapro Inc
Cash & Cash Equivalents
Ceapro Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ceapro Inc
XTSX:CZO
|
Cash & Cash Equivalents
CA$8.8m
|
CAGR 3-Years
18%
|
CAGR 5-Years
37%
|
CAGR 10-Years
16%
|
|
|
Burcon NutraScience Corp
TSX:BU
|
Cash & Cash Equivalents
CA$1m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-13%
|
|
|
EcoSynthetix Inc
TSX:ECO
|
Cash & Cash Equivalents
$3.9m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-25%
|
|
|
5N Plus Inc
TSX:VNP
|
Cash & Cash Equivalents
$24.6m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
Neo Performance Materials Inc
TSX:NEO
|
Cash & Cash Equivalents
$64.9m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Ceapro Inc
Glance View
Ceapro, Inc. engages in the development and marketing of natural products for personal care, cosmetic, human, and animal health industries. The company is headquartered in Edmonton, Alberta. The firm's primary business activities relate to the development and marketing of various health and wellness products and technology relating to plant extracts. The firm operates through two segments: the active ingredient product technology industry and the cosmeceutical industry. The firm is engaged in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. The company supports the use of its extracts in cosmeceutical, nutraceutical and therapeutic products for humans and animals. Its pipeline Oat Beta Glucan and Avenanthramides. The Company’s wholly owned subsidiaries include Ceapro Technology Inc., Ceapro Active Ingredients Inc., Ceapro BioEnergy Inc., Ceapro (P.E.I) Inc., Ceapro USA Inc., and JuventeDC Inc.
See Also
What is Ceapro Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
8.8m
CAD
Based on the financial report for Dec 31, 2023, Ceapro Inc's Cash & Cash Equivalents amounts to 8.8m CAD.
What is Ceapro Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
16%
Over the last year, the Cash & Cash Equivalents growth was -36%. The average annual Cash & Cash Equivalents growth rates for Ceapro Inc have been 18% over the past three years , 37% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
